Contributors
Latest:
CURE Community Vlogs: How One Woman Found Her Way Out of Depression Following Metastatic Breast CancerAfter being diagnosed with metastatic breast cancer, nurse Stephanie Walker was thrown into a world of isolation and new depths of depression she “never knew even existed”. Here, she details how working with a therapist and communicating with her family and friends helped her find her way out of the darkness.
Latest:
Survivors of Tranplantations Should Be Aware of Potential Late EffectsMinimizing and preventing late effects of stem cell transplantation.
Latest:
Returning to Work After TreatmentKnow your rights and make a plan to help ensure a smooth transition back into the workforce.
Latest:
Celestia S. Higano on Sexual Health and Pelvic Floor PhysiotherapyThis research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.
Latest:
Mapping Out the Care Team in Cancer SurvivorshipPatricia J. Goldsmith, CEO of CancerCare, discusses the importance of coordinating between health care professionals as a patient moves into survivorship and converts to treating cancer as a chronic illness.
Latest:
Burst Your BubbleAfter treatment, this survivor was terrified of everyone and everything until her very wise doctor said, “I did not put you through all this for you to put yourself in a bubble – go live your life.” And she has… for 16 years and counting.
Latest:
Common Mutations Could Lead to Targeted Treatment for Patients with Brain MetastasesWhile scientists have a limited understanding of how brain metastases genetically evolve from their primary tumor, research presented at the Society for Neuro-Oncology’s Annual Meeting may have identified a connection between genetic mutations and treatment options that could offer patients improved outcomes.
Latest:
Tracking a Mystery in Non-Secretory MyelomaThere is no difference in treatment for non-secretory multiple myeloma and multiple myeloma, an expert told CURE®.
Latest:
Everybody Dies, With or Without CancerCancer may throw off a "plan" of where, when, why and how death happens.
Latest:
Jennifer Arnold on the Importance of ListeningJennifer Arnold, our MPN Heroes guest speaker, a physician and star of TLC’s reality TV show “The Little Couple,” discusses the importance of doctors and caregivers taking a moment to listen to patients and see how they are feeling.
Latest:
Delicate Difference: More Surgical Options for Prostate CancerInnovative approaches offer more surgical options with potentially fewer side effects.
Latest:
Personalized Precision Cancer Therapy Offers New Hope"My dream is for the day when all cancer patients can have testing to find out what treatment approach might work best for them—so that a patient with a specific genomic profile doesn’t miss an opportunity to get a potentially life-saving treatment when it’s out there."
Latest:
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease TypesSuresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Latest:
11 Years After Losing My Hair to Chemo, I Decided to Donate My Locks to Children With CancerA breast cancer survivor explains why she was inspired to donate her hair to make wigs for children with cancer 11 years after she lost her own hair during chemotherapy treatments.
Latest:
PD-L1: An Important, But Imperfect BiomarkerSome immunotherapy drugs target the PD-L1 protein, though this expert says that it is still an imperfect biomarker.
Latest:
Novel HER-2 Targeted Agents Show Promise in Treating CNS MetastasesA recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.
Latest:
Brukinsa Viabie for Calquence-Intolerant B-Cell MalignanciesResults from an ongoing phase 2 study show the viability for the use of Brukinsa after patients with previously treated B-cell malignancies are deemed intolerant to the next-generation Bruton tyrosine kinase inhibitor Calquence.
Latest:
Gary Mervis on Putting Cancer on the "Front Burner"Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).
Latest:
Sponsored Content: Grandmother With Advanced Bladder Cancer Finds Hope When Options Were LimitedBladder cancer is the sixth most common cancer in the U.S.
Latest:
Caregiver Challenge: Sharing Their PainCaregivers may grapple with practical and emotional challenges as they help loved ones manage cancer-related pain.
Latest:
Pairing Up Against Triple-Negative Breast CancerLinking a targeted drug to a chemotherapy shows promise for treating metastatic triple-negative breast cancer.
Latest:
Patient With Lung Cancer ‘Stays One Step Ahead’ of His Rare MutationA man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.
Latest:
I’m Thankful for Early Cancer DetectionEven though I had no symptoms, my prostate cancer was caught thanks to frequent follow-ups with my doctor.
